MOSCOW, May 20. The company producing brain chips Neuralink of American entrepreneur Elon Musk received permission from the American Ministry of Health to implant the Telepathy implant into the brain of the second participant in the experiment, the publication reports Wall Street Journal.
“The US Food and Drug Administration (FDA) gave the green light to Elon Musk’s Neuralink to implant its brain chip in a second person, accepting the company’s proposed fixes for a problem that the first participant in the text had,” the publication writes. with a link to the document. 
By his information, to correct the problem with outgoing ultra-thin wires, which the company previously reported, it is proposed to embed some of the wires deeper into the brain.
Neuralink previously said that the implant's tiny wires came loose from a patient's brain during a first-in-human trial, reducing the number of electrodes that can measure brain signals.
In January, Musk announced that the first person had received the Neuralink implant and was doing well. According to the businessman, the first data obtained on the operation of the device show promising results.
Musk later wrote that the new Neuralink device is called Telepathy. It gives the owner the ability to control a smartphone or computer using the power of thought and is primarily created for people who have lost the ability to use their limbs. In March, the first patient with the implant showed how he plays chess “with the power of thought.” 
< br />At the same time, Musk announced a brain implant from the company Neuralink, which is conceived as a device that allows blind people to see. The next project is called Blindsight.
Earlier, US health inspectors discovered problems with record keeping and quality control of animal experiments at Musk's California center. -0-
Recent Comments